Clinical trial Recruiting at 1 site Observational

Genetic exploration of primary immunodeficiencies

Official title: Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies

Run by University Children's Hospital, Zurich · NCT02735824 · Data updated 2026-11-12

This study is trying to find new genetic causes of primary immunodeficiencies in people who have frequent infections by comparing their genetic information with that of healthy individuals.

Quick facts

Study typeObservational
SexAll
Enrollment500 (estimated)
SponsorUniversity Children's Hospital, Zurich
Academic / other
Locations1 site (Zurich, Canton of Zurich)
StatusRecruiting
StartedFebruary 2016
Main results expectedJuly 2027
Study endsDecember 2027
Registry record updatedMay 14, 2026
Trial IDNCT02735824 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with suspected primary immunodeficiency and their healthy relatives.

Probably not a fit

Patients without suspected immunodeficiency or those who do not have healthy relatives willing to participate may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates individuals with suspected primary immunodeficiency by comparing their genetic data with that of healthy controls. Participants will provide blood samples during routine procedures, and additional samples may be collected from healthy family members. The goal is to identify new genetic causes of immunodeficiency, which may present as recurrent infections or immune dysregulation. The study is observational and does not involve any experimental treatments.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and diagnosis of primary immunodeficiencies, ultimately improving patient care.

How similar studies have gone: Other studies have successfully identified genetic causes of immunodeficiencies, suggesting that this approach may yield valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients: Pediatric patients (in/outpatient or referred) with suspected or confirmed Inborn Errors of Immunity.
* Relatives: Healthy or affected biological relatives of enrolled patients.
* Controls: Healthy volunteers with no history of chronic immunological, inflammatory, or infectious disease.
* Consent: Ability to provide signed informed consent (or guardian consent).

Where it's running

  • Division of Immunology
    Zurich, Canton of Zurich, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.